SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000920465-17-000060
Filing Date
2017-07-31
Accepted
2017-07-28 18:48:13
Documents
4
Period of Report
2017-07-31
Effectiveness Date
2017-07-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A proxy2017.htm DEF 14A 713747
2 image1a03.jpg GRAPHIC 164429
3 lajolla2018proxycard001.jpg GRAPHIC 117896
4 lajolla2018proxycard002.jpg GRAPHIC 106215
  Complete submission text file 0000920465-17-000060.txt   1239748
Mailing Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121
Business Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36282 | Film No.: 17991207
SIC: 2836 Biological Products, (No Diagnostic Substances)